Auspex Pharmaceuticals Priced, Nasdaq: ASPX
Late-stage biotech developing treatments for CNS disorders.
Industry: Health Care
First Day Return: +30.5%
Industry: Health Care
ASPX
Late-stage biotech developing treatments for CNS disorders.
| IPO Data | |
|---|---|
| IPO File Date | 12/20/2013 |
| Offer Price | $12.00 |
| Price Range $10.00 - $12.00 | |
| Offer Shares (mm) | 7.0 |
| Deal Size ($mm) | $84 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 02/04/2014 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $84 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | San Diego, CA, United States |
| Founded | 2001 |
| Employees at IPO | 13 |
| Website www.auspexpharma.com | |
IPO News for Auspex Pharmaceuticals
Auspex Pharmaceuticals (ASPX) Performance
